Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S de Bono

Showing results (61-70 of 492) with videos related to

Pageof 50
Sort By:
Future Oncology (London, England)|August 31, 2010
Early oncology clinical trial design in the era of molecular-targeted agentsAndre T Brunetto, Rebecca S Kristeleit, Johann S de Bono
Cancer Metastasis Reviews|January 7, 2014
Novel drugs targeting the androgen receptor pathway in prostate cancerJoaquin Mateo, Alan Smith, Michael Ong, et al.
Drugs|February 14, 2016
Managing Metastatic Castration-Resistant Prostate Cancer in the Pre-chemotherapy Setting: A Changing Approach in the Era of New Targeted AgentsZafeiris Zafeiriou, Anuradha Jayaram, Adam Sharp, et al.
Acta Neuropsychiatrica|July 12, 2016
Screening for distress including anxiety and depression in patients with cancer during in-patient admissionsS Lee, L Katona, S de Bono, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 23, 2016
Targeting Androgen Receptor Aberrations in Castration-Resistant Prostate CancerAdam Sharp, Jonathan Welti, Julian Blagg, et al.
Seminars in Oncology|November 13, 2003
Farnesyltransferase inhibitors and their potential in the treatment of breast carcinomaJohann S de Bono, Anthony W Tolcher, Eric K Rowinsky
Expert Opinion on Investigational Drugs|September 28, 2010
Horizon scanning for novel therapeutics for the treatment of prostate cancerDiletta Bianchini, Andrea Zivi, Shahneen Sandhu, et al.
European Urology Focus|July 21, 2017
Optimal Treatment Sequence for Metastatic Castration-resistant Prostate CancerDavid Lorente, Karim Fizazi, Christopher Sweeney, et al.
Molecular Cancer Therapeutics|August 13, 2009
Predictive biomarkers for targeting insulin-like growth factor-I (IGF-I) receptorCraig P Carden, L Rhoda Molife, Johann S de Bono
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 1, 2010
Abiraterone acetate is well tolerated without concomitant use of corticosteroidsGerhardt Attard, Alison H M Reid, Johann S de Bono
Pageof 50

Showing results (61-70 of 492) with videos related to

Sort By:
Pageof 50
Future Oncology (London, England)|August 31, 2010
Early oncology clinical trial design in the era of molecular-targeted agentsAndre T Brunetto, Rebecca S Kristeleit, Johann S de Bono
Cancer Metastasis Reviews|January 7, 2014
Novel drugs targeting the androgen receptor pathway in prostate cancerJoaquin Mateo, Alan Smith, Michael Ong, et al.
Drugs|February 14, 2016
Managing Metastatic Castration-Resistant Prostate Cancer in the Pre-chemotherapy Setting: A Changing Approach in the Era of New Targeted AgentsZafeiris Zafeiriou, Anuradha Jayaram, Adam Sharp, et al.
Acta Neuropsychiatrica|July 12, 2016
Screening for distress including anxiety and depression in patients with cancer during in-patient admissionsS Lee, L Katona, S de Bono, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 23, 2016
Targeting Androgen Receptor Aberrations in Castration-Resistant Prostate CancerAdam Sharp, Jonathan Welti, Julian Blagg, et al.
Seminars in Oncology|November 13, 2003
Farnesyltransferase inhibitors and their potential in the treatment of breast carcinomaJohann S de Bono, Anthony W Tolcher, Eric K Rowinsky
Expert Opinion on Investigational Drugs|September 28, 2010
Horizon scanning for novel therapeutics for the treatment of prostate cancerDiletta Bianchini, Andrea Zivi, Shahneen Sandhu, et al.
European Urology Focus|July 21, 2017
Optimal Treatment Sequence for Metastatic Castration-resistant Prostate CancerDavid Lorente, Karim Fizazi, Christopher Sweeney, et al.
Molecular Cancer Therapeutics|August 13, 2009
Predictive biomarkers for targeting insulin-like growth factor-I (IGF-I) receptorCraig P Carden, L Rhoda Molife, Johann S de Bono
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 1, 2010
Abiraterone acetate is well tolerated without concomitant use of corticosteroidsGerhardt Attard, Alison H M Reid, Johann S de Bono
Pageof 50